Skip to main content
Wholesale Pricing for Licensed Professionals

In-office procedures · Diagnostic test

InflammaDry A 10-minute MMP-9 tear test.

A CLIA-waived point-of-care test that flags elevated MMP-9 in tears, used by optometrists and ophthalmologists alike.

Product photo of Inflammadry MMP-9 Testing
10 minResult time
40 ng/mLClinical cutoff for MMP-9
98%Negative agreement
80.3%Positive agreement

How the test works

The sampling fleece picks up tears directly, and the sample runs on a lateral flow immunoassay that uses direct sampling microfiltration. Two antibodies capture MMP-9, and a two-color line readout shows whether it is elevated.

Flags inflammation

Picks up elevated MMP-9, an inflammatory marker frequently raised in the tears of dry eye patients.

10-minute results

Four simple steps produce a result within the same visit.

CLIA-waived

Built for point-of-care use in an eye care practice.

Nothing else to buy

Ready out of the box, with no reader and no refrigeration needed.

Inside each test

Every test includes a sterile sample collector, a buffer and a test cassette.

  • Point-of-care, CLIA-waived
  • 10-minute results
  • Stored without refrigeration
  • Sample collector

    A sterile collector with a contoured tip and Dacron sampling fleece that collects tears directly.

  • Test cassette

    A plastic cassette holding a lateral flow immunoassay strip built on direct sampling microfiltration.

  • Two-color result

    A blue control line means the test is valid. Red and blue lines together read positive, and blue alone reads negative.

  • External controls

    Positive and negative controls confirm the test is performing and help with staff training.

Where it fits in the workup

Run InflammaDry as part of the dry eye workup, before anesthetic, dyes or Schirmer testing.

Sample

Tears picked up directly from the eye by the sterile fleece. No pipettes and no extra equipment.

Time to result

Four steps and a 10-minute wait for a visual result.

CLIA-waived

Prescription use only, at point-of-care sites. Controls go in with every new lot, every new shipment and every 30 days.

Stock InflammaDry

Specifications and safety information

Technical specifications
Sample type Human tears
Analyte MMP-9 (matrix metalloproteinase-9)
Clinical cutoff 40 ng/mL
Time to result 10 minutes
Result format Visual, qualitative, two-color lines
Positive agreement 80.3%
Negative agreement 98%
CLIA status Waived
Storage 4°C to 25°C (39°F to 77°F)
Test kit RPS-ID-20-U, 20 tests
Control kit RPS-DESTD, 1 positive and 1 negative control
External controls Each new lot, each new shipment and every 30 days
Indications for use

InflammaDry is a rapid, immunoassay test for the visual, qualitative in vitro detection of elevated levels of the MMP-9 protein in human tears from patients suspected of having dry eye to aid in the diagnosis of dry eye in conjunction with other methods of clinical evaluation. This test is intended for prescription use at point-of-care sites.

Warnings and precautions
  • For prescription use only.
  • Slit-lamp biomicroscopy is required to eliminate patients with active intraocular inflammation.
  • InflammaDry requires a visual readout. Do not interpret the test result if you have color-impaired vision.
  • The Dacron material used in the Sampling Fleece may cause allergic reactions for some people.
  • InflammaDry should be performed prior to instilling ocular anesthetic, topical dyes, or performing Schirmer testing.
  • Certain medications may cause erroneous results if used immediately before taking a sample. If ocular anesthetic or any other topical medication has been applied to the eye, wait at least 2 hrs prior to collecting a sample.
  • Certain medications such as systemic immunomodulators, topical or oral steroids, cyclosporine, tetracycline and topical azithromycin are known to inhibit metalloproteinase activity. Use of these medications may lead to false negative results.

Treatment paths

Where testing leads: the dry eye treatment paths

Dry eye care runs from home care to surgery, and many patients use several paths at once. Vision Rescue does not rank these paths; the treating doctor and the patient choose based on severity, the main driver and the patient's circumstances.

At-home and OTC care

Lubricant drops, gels and ointments, lid hygiene, warm compresses and nutrition. Usually the base layer at every severity.

Recommended by optometrists and ophthalmologists; done by the patient at home. Product guides ›

Prescription therapy

Anti-inflammatory and tear-film drugs such as cyclosporine, lifitegrast and perfluorohexyloctane, varenicline nasal spray, lotilaner for Demodex and short steroid courses.

Prescribed by ophthalmologists and optometrists within state scope. Prescription options ›

In-office procedures

Gland expression, thermal pulsation and lid-heating devices, intense pulsed light, light therapy and lid-margin cleaning.

Offered in optometry and ophthalmology practices, often run by trained staff. In-office procedures ›

Punctal occlusion

Temporary or long-lasting plugs that keep the patient's own tears on the eye, and permanent closure by thermal cautery when plugs are not enough.

Plugs placed by ODs and MDs where state scope allows; cautery closure is a surgical step, usually by an ophthalmologist. Punctal plugs ›

Advanced and surgical care

For severe disease: autologous serum drops, amniotic membrane, scleral lenses and eyelid surgery such as tarsorrhaphy.

Often cornea and oculoplastic specialists, with the co-managing OD or MD. Scleral lenses ›

Sources: TFOS DEWS III Management and Therapy (2025) · AAO Dry Eye Syndrome PPP (2023)

Manufacturers

Companies named on this page

Logos link to each company's website and appear in alphabetical order, at the same size, for identification only.

QuidelOrtho logo

Questions doctors ask about InflammaDry

What does the test detect?

Elevated MMP-9, an inflammatory marker frequently raised in the tears of dry eye patients. The cutoff used clinically is 40 ng/mL.

How long until the result?

The result is ready in 10 minutes.

Is it CLIA-waived?

Yes. It is CLIA-waived and meant for use by prescribers at point-of-care sites.

What are the storage requirements?

Store between 4°C and 25°C (39°F to 77°F). Refrigeration is not needed, and the test and buffer stay stable until the expiration date printed on the package.

How often do external controls need to be run?

With every new lot, every new shipment and every 30 days.

At what point in the exam should it be run?

Before any ocular anesthetic, topical dye or Schirmer testing. If a topical medication has gone in the eye, allow at least 2 hours before taking the sample.

Do optometrists and ophthalmologists both use InflammaDry?

Yes. InflammaDry is used in optometry and ophthalmology practices, from primary eye care to cornea and surgical practices that check the ocular surface before surgery. Who may run and bill the test follows state scope of practice and the manufacturer's instructions.

Bring MMP-9 testing into your dry eye workup

A 10-minute, CLIA-waived test showing whether MMP-9 is elevated in a patient suspected of dry eye.

Stay current: Latest eye care industry news

InflammaDry is a trademark of QuidelOrtho. Read the complete manufacturer instructions for use, including every warning, precaution and contraindication, before use. Individual results vary.